The government has sent inspectors to
Florence's Careggi to look into its treatment of minors with
gender dysphoria (GD) and the use of drug triptorelin.
GD regards people who experience a mismatch between their gender
identity and their sex assigned at birth.
Triptorelin is sometimes used to delay puberty in patients with
GD to give them time to gain awareness of their gender identity
and prepare for the psychological, medical, developmental,
social and legal issues that may lie ahead of them.
"It's just a check of what has been done and whether the
regulations have been followed," said Health Minister Orazio
Schillaci on Wednesday in relation to the inspection.
"It is absolutely not a punitive gesture".
Mara Campitiello, the head of the minister's technical
secretariat, told ANSA that Schillaci will receive the
inspectors' report within 15 days.
ALL RIGHTS RESERVED © Copyright ANSA
